An O-Antigen Glycoconjugate Vaccine Produced Using Protein Glycan Coupling Technology Is Protective in an Inhalational Rat Model of Tularemia. (2018)

First Author: Marshall LE
Attributed to:  Development and testing of novel recombinant pnemococcal glyconjugate vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1155/2018/8087916

PubMed Identifier: 30622981

Publication URI: http://europepmc.org/abstract/MED/30622981

Type: Journal Article/Review

Volume: 2018

Parent Publication: Journal of immunology research

ISSN: 2314-7156